<DOC>
	<DOCNO>NCT02446548</DOCNO>
	<brief_summary>The study randomise , double-blind , control 2 x 3 cross-over trial renal effect therapy aliskiren ( A ) , placebo ( P ) losartan ( L ) compare . It consist 8-week run-in period , 8 week active treatment aliskiren losartan ( period 1 ) , 8 week active treatment alternative medication ( period 2 ) , 8-week placebo administration .</brief_summary>
	<brief_title>Influence Aliskiren Albuminuria After Kidney Transplantation</brief_title>
	<detailed_description>At begin , subject meet inclusion criterion enter 8-week run-in screening period . All hypotensive group drug allow exception ACEI , ARA , DRI mineralocorticoid receptor antagonist . The target BP office trough BP 140/90 mmHg less . At end run-in period , patient randomly allocate one two treatment sequence : L/P/A ( sequence 1 ) A/P/L ( sequence 2 ) . The study medication introduce single hypotensive drug add current hypotensive agent , dosage , adjust run-in period , leave unchanged throughout study . Losartan use dose 50 mg aliskiren administer dose 150 mg. Drug compliance assess tablet count . Patients recommend change usual daily protein sodium intake study period . Dosage cyclosporine tacrolimus allow change either . At end three treatment period , office thorough BP , 24-h ambulatory BP , albuminuria , serum creatinine potassium , haemoglobin , cyclosporine tacrolimus level , urine excretion NAG , TGF-Î²-1 15-F2t-isoprostanes determine . eGFR calculate . Patients also ask fill questionnaire measure patients-reported side effect .</detailed_description>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>1 . Transplantation period 6 month , 2 . Calcineurin inhibitor ( cyclosporine tacrolimus ) base immunosuppression , 3 . Stable cyclosporine tacrolimus trough level last three month ( variation 25 % ) , 4 . Stable renal function define eGFR &gt; 30 ml/min ( variation 5 ml/min/1.73 m2 last 3 month ) , 5 . Arterial hypertension treat one two antihypertensive agent blood pressure ( BP ) &gt; 130/80 mmHg patient treat yet , 6 . Albuminuria &gt; 30 mg/g creatinine . 1 . Pregnant possibility become breast feeding . 2 . Angioedema ACE inhibitor ARA history . 3 . Serum potassium great 5.5 mmol/l two occasion precede three month . 4 . Graft artery stenosis ( i.e . psv 200 cm/s doppler usg ) 5 . Left ventricular dysfunction require ACE inhibitor ARA Protocol Version 1 p. 5 10 6 . New immunosuppressive agent start previous immunosuppressant stop three month prior study entry plan switch immunosuppressive agent within next three month . 7 . Currently four blood pressure pill average blood pressure three visit great 150/100 . 8 . Currently ACEinhibitor ARAor treatment ACE inhibitor ARA kidney transplantation last 3 month . 9 . Had acute coronary syndrome , episode malignant hypertension , stroke transient ischaemic attack three month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>direct renin inhibitor</keyword>
	<keyword>kidney transplantation</keyword>
	<keyword>albuminuria</keyword>
</DOC>